These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2122594)

  • 21. [Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center].
    Roguin A; Ben Arush MW; Higasi A; Kuten A
    Harefuah; 1996 Apr; 130(8):511-4, 584. PubMed ID: 8765870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ifosfamide-induced hemorrhagic cystitis and its prevention by mesna].
    Matsumoto S; Kawaguchi N; Manabe J; Kuroda H; Shimoji T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):965-8. PubMed ID: 7794006
    [No Abstract]   [Full Text] [Related]  

  • 23. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: a single hospital experience.
    Pratt CB; Luo X; Fang L; Marina N; Avery L; Furman WL
    Med Pediatr Oncol; 1996 Sep; 27(3):145-8. PubMed ID: 8699990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide.
    Mace JR; Keohan ML; Bernardy H; Junge K; Niebch G; Romeis P; Thoma A; Wagner T; Mueller U; Demetri G; Baker LH
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5829-34. PubMed ID: 14676103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of ifosfamide in children with malignant solid tumors.
    Pratt CB; Horowitz ME; Meyer WH; Etcubanas E; Thompson EI; Douglass EC; Wilimas JA; Hayes FA; Green AA
    Cancer Treat Rep; 1987 Feb; 71(2):131-5. PubMed ID: 3100034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Palackdharry CS
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma].
    Chen LK; Xu GC; Teng XY; Liang Y; Liu JL; Zhou XM
    Ai Zheng; 2002 Aug; 21(8):903-6. PubMed ID: 12478904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epileptic seizures and treatment with ifosfamide-mesna].
    Somma-Mauvais H; Farisse P; Viallat JR
    Rev Neurol (Paris); 1994; 150(4):307-8. PubMed ID: 7863185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors.
    Schneider CP; Merkel U; Grübner U; Kath R; Höffken K; Hoffmann A
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):313-8. PubMed ID: 12073049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Li EX; Zhang YT; Shang JT; Xu Z; Geng Y; Li SM; Shi F; Wu YY
    Ai Zheng; 2006 Aug; 25(8):1048-51. PubMed ID: 16965692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ifosfamide in the treatment of pediatric malignancies.
    Voûte PA; van den Berg H; Behrendt H; Michiels E; de Kraker J
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):8-11. PubMed ID: 8711502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
    Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
    Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
    Girón CG; Ordónez A; Jalón JI; Barón MG
    Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ifosfamide in pediatric malignant solid tumors.
    Pratt CB; Douglass EC; Etcubanas EL; Goren MP; Green AA; Hayes FA; Horowitz ME; Meyer WH; Thompson EI; Wilimas JA
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S24-7. PubMed ID: 2503257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC; Solidoro A; Casanova L; Vallejos C; Rodriguez W
    J Exp Ther Oncol; 1996 Mar; 1(2):84-7. PubMed ID: 9414391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.